Thymalin
البحوث المنشورة وقاعدة الأدلة
Thymalin is a polypeptide complex extracted from calf thymus, developed in the Soviet Union by Morozov and Khavinson and used in Russia as an immunocorrective medicine; the dipeptide Thymogen (Glu-Trp) was later isolated from it. Cell studies from the developing group reported that Thymalin promoted differentiation of human haematopoietic stem cells toward mature T cells and reduced inflammatory cytokine production, effects attributed to short peptides such as KE and EW. Mouse studies in the 1980s reported longer life span and fewer spontaneous tumours with the thymus polypeptide factor, and a 6-8-year study in 266 older people reported lower respiratory disease incidence and mortality with Thymalin with or without Epithalamin. During the COVID-19 pandemic the same group reported faster normalisation of inflammatory and coagulation markers and lower hospital mortality when Thymalin was added to standard care. Much of this evidence comes from the developing group and its collaborators, with further small Soviet and Russian clinical studies from other centres in infections, surgery, endocrine and skin disease; much of it is in Russian, and the clinical studies were small and not described as blinded or randomised.
- Thymalin هو مركب ببتيدي متعدد مستخلص من غدة التوتة لدى العجول.
- أفادت دراسات على كبار السن بانخفاض أمراض الجهاز التنفسي والوفيات.
- كانت الدراسات صغيرة وغير معمّاة أو عشوائية، ومعظمها منشور بالروسية.
34 دراسة · 1 منذ 2023 · الأحدث 2023
- الدراسات المذكورة
- 34
- منشورة 2023+
- 1
- أحدث ورقة بحثية
- 2023
- آخر مراجعة
- أكتوبر 2026
المواضيع المتكررة في الأدبيات
- calf thymus polypeptide extract
- T-cell differentiation and immunomodulation
- geroprotection and life span in mice
- COVID-19 adjunct therapy
- Khavinson peptide bioregulators
- Russian-language clinical literature
34 دراسة منشورة.
مرتبة حسب قوة تصميم الدراسة، ثم حسب الحداثة. كل إدخال يرتبط بالسجل المصدري حتى يمكن التحقق من النتيجة مقابل الورقة البحثية بدلاً من الاعتماد على كلامنا.
- 01سريري بشري2022· Russian (English abstract)
Morphological compound and indicators of the blood clotting system in severe COVID-19 patients of middle aged and elderly during treatment of Tocilizumab and Thymalin
Kuznik BI, et al. · Adv Gerontol · middle-aged and elderly patients with severe COVID-19 in three groups: basic therapy, basic therapy plus tocilizumab, basic therapy plus Thymalin
Hospital mortality was 40.9% with standard therapy, 28.4% with tocilizumab and 20.6% with Thymalin. Thymalin increased lymphocyte and monocyte counts, lowered the neutrophil-to-lymphocyte ratio and reduced fibrinogen, lactate dehydrogenase and D-dimer.
- 02سريري بشري2021
Peptide Drug Thymalin Regulates Immune Status in Severe COVID-19 Older Patients
Kuznik B, et al. · Adv Gerontol · older patients hospitalised with severe COVID-19: Thymalin added to standard therapy (n = 36) versus standard therapy alone (n = 44); allocation method not stated in the abstract
Patients receiving Thymalin with standard therapy showed faster clinical improvement, more frequent recovery from lymphopenia and faster normalisation of C-reactive protein, D-dimer, lymphocyte and NK-cell counts than patients on standard therapy alone. The authors reported that hospital mortality was halved in the Thymalin group.
- 03سريري بشري2021
Results and Prospects of Using Activator of Hematopoietic Stem Cell Differentiation in Complex Therapy for Patients with COVID-19
Khavinson VK, et al. · Stem Cell Rev Rep · patients with COVID-19 receiving standard therapy with or without Thymalin (group sizes not given in the abstract)
Adding Thymalin to standard therapy accelerated the decline in IL-6, C-reactive protein and D-dimer and the recovery of T-cell indices compared with standard treatment alone. The authors linked the immunomodulatory effect to Thymalin's reported influence on haematopoietic stem cell differentiation.
- 04سريري بشري2015
Chrono- and Immunocorrection of Inflammatory Disorders of Internal Reproductive Organs in Women of Reproductive Age
Litvinenko GI, et al. · Bull Exp Biol Med · women of reproductive age with chronic salpingitis and oophoritis treated with Thymalin or ridostin, timed according to lymphocyte succinate dehydrogenase response
Lymphocyte succinate dehydrogenase responses to Thymalin and ridostin showed diurnal variation between individuals. When either drug was given at times when lymphocytes responded, more patients showed improvement in clinical, laboratory and immunological parameters than when it was given in the absence of a response.
- 05سريري بشري2012· Russian (English abstract)
[The use of Timalin in the treatment of the acute lung abscess].
Tsybikov MN, et al. · Khirurgiia (Mosk) · controlled clinical study in patients with acute lung abscess: traditional treatment with or without added Timalin; n not stated in the abstract
Adding Timalin was reported to bring faster normalisation of the main systemic inflammatory response indicators and of plasma fibrinolytic activity, and to eliminate hypercoagulation.
- 06سريري بشري2003
Peptides of pineal gland and thymus prolong human life
Khavinson VKh, et al. · Neuro Endocrinol Lett · 266 elderly and older people followed for 6-8 years, Thymalin and/or Epithalamin given during the first 2-3 years, compared with a control group; indexed as a randomised trial but the abstract does not describe randomisation, blinding or allocation
The authors reported improvement in cardiovascular, endocrine, immune and nervous system indices, a 2.0-2.4-fold lower incidence of acute respiratory disease and lower mortality over the observation period: 2.0-2.1-fold in the Thymalin group and 2.5-fold with Thymalin plus Epithalamin, compared with control.
- 07سريري بشري2000· Russian (English abstract)
[Circulating immune complexes in acute concussion of the brain].
Midlenko AI, et al. · Zh Vopr Neirokhir Im N N Burdenko · comparative study in children with acute brain concussion: laser exposure to the carotid and vertebral arteries or to acupuncture points, with thymalin used for comparison; circulating immune complexes followed over 3 weeks; n not stated in the abstract
Circulating immune complexes rose progressively over 3 weeks. Laser exposure lowered them significantly by days 19-21, particularly at acupuncture points, whereas thymalin did not affect blood levels of circulating immune complexes.
- 08سريري بشري2000· Russian (English abstract)
[Effects of thymalin on blood coagulation and contents of proinflammatory and anti-inflammatory cytokines in patients with burns].
Kuznik BI, et al. · Vestn Khir Im I I Grek · comparative clinical study, n=32 patients with third- and fourth-degree burns treated with thymalin; comparison group not described in the abstract
Thymalin was reported to help resolve disseminated intravascular coagulation, normalise fibrinolysis and change pro- and anti-inflammatory cytokine levels. The first autodermoplasty took place on average 5 days earlier and hospital stay was 11 days shorter.
- 09سريري بشري1999· Russian (English abstract)
Thymalin in the combined treatment of parkinsonism patients
Musienko GV · Lik Sprava · 15 patients aged 45-72 with idiopathic parkinsonism (UPDRS stages 1.5-2.5), before-and-after design without a control group
After a course of Thymalin the author reported improvement in general well-being, tremor, rigidity and hypokinesia and in a measure of central nervous system biological age. EEG mapping showed reduced alpha-rhythm power in anterocentral brain regions.
- 10سريري بشري1994· Russian (English abstract)
[Effect of plasmapheresis and immunocorrective therapy on the status of the T-cell component of immunity in patients with autoimmune thyroiditis].
Kalinin AP, et al. · Probl Endokrinol (Mosk) · controlled clinical study, 104 patients with autoimmune thyroiditis: plasmapheresis alone in 22, plasmapheresis plus thymalin in 82 (with thyroid hormone replacement in 49 with hypothyroidism), 1-year follow-up; allocation method not stated in the abstract
Plasmapheresis alone gave only a short-term positive effect. Combined therapy including thymalin was reported to give a stable clinical and immunological effect, with recovery of T-lymphocyte subpopulations and their functional activity over 1 year of follow-up.
- 11سريري بشري1994· Russian (English abstract)
[Thymalin in the treatment of herpetic stomatitis in children].
Kazantseva IA, Bikbulatov RM · Stomatologiia (Mosk) · clinical study, n=44 children with acute and relapsing herpetic stomatitis treated with thymalin, with virological and lymphocyte-subset monitoring; comparison group not described in the abstract
Thymalin did not bring a rapid abatement of acute stomatitis symptoms. The authors reported a stable anti-relapse effect in children at high risk of recurrence.
- 12سريري بشري1992· Russian (English abstract)
[Differentiated immunocorrective therapy in nonspecific ulcerative colitis].
Tkach SM, et al. · Lik Sprava · controlled comparative clinical trial, n=50 patients with ulcerative colitis of different activity grades treated with corticosteroids or thymalin
Efficacy depended on disease activity: corticosteroids were more effective with inflammatory-destructive changes of the colonic mucosa, while thymalin was preferred in mild inflammation with predominantly ulcerative-reparative changes.
- 13سريري بشري1991· Russian (English abstract)
[The use of thymalin in the combined treatment of patients with disseminated cancer of the cervix uteri].
Vishnevskaia EE, et al. · Vopr Onkol · controlled clinical study in women with advanced cervical carcinoma: 38 received split-course radiotherapy plus thymalin immunotherapy and fifty-eight controls received radiotherapy alone; allocation method not stated in the abstract
Adding thymalin to radiotherapy was reported to allow wider use of radical surgery and to give better treatment results than radiotherapy alone. Survival figures are not given in the abstract.
- 14سريري بشري1991· Russian (English abstract)
[The effect of combined therapy with the use of thymalin and piracetam on the level of middle-molecule peptides in the blood and on the lipid peroxidation activity in patients with diffuse toxic goiter].
Iangolenko VV · Ter Arkh · controlled clinical study in diffuse toxic goitre: of 104 patients examined, 66 with moderate disease were treated in 5 groups (mercazolyl; lithium carbonate; mercazolyl plus thymalin; mercazolyl plus piracetam; mercazolyl plus thymalin and piracetam) until euthyroidism
The regimen of mercazolyl with thymalin and piracetam was reported to have a beneficial effect on blood middle-molecule peptides, lipid peroxidation activity and the clinical course. Results for the mercazolyl-plus-thymalin group alone are not given in the abstract.
- 15سريري بشري1990
Application of thymic factor "Thymalin" in complex treatment of endometrial cancer patients
Bakhidze EV, et al. · Eur J Gynaecol Oncol · 111 patients with primary endometrial cancer receiving hormone therapy plus surgery, of whom 35 also received Thymalin
Combined hormonal and surgical treatment was associated with suppression of T-lymphocyte indices. Patients who also received Thymalin showed positive effects on cellular immunity and on some clinico-morphological parameters.
- 16سريري بشري1990· Russian (English abstract)
[Use of thymic peptide thymalin in the complex treatment of therapy-resistant schizophrenia].
Govorin NV, Stupina OP · Zh Nevropatol Psikhiatr Im S S Korsakova · uncontrolled clinical trial, n=36 patients with therapy-resistant schizophrenia and marked immune abnormalities, thymalin added to psychotropic drugs
Adding thymalin was reported to eliminate or ameliorate psychic disorders, activate patients and reduce neuroleptic complications. Clinical improvement correlated with normalisation of immune abnormalities.
- 17سريري بشري1989· Russian (English abstract)
[The use of thymalin in the combined chemotherapy of patients with infiltrative destructive pulmonary tuberculosis].
Ivanova LA · Vrach Delo · controlled clinical study, 116 patients with infiltrative destructive pulmonary tuberculosis: 76 in the main group received thymalin early in chemotherapy and the remainder formed a control group; allocation method not stated in the abstract
Adding thymalin to chemotherapy was reported to raise treatment efficacy earlier than in the control group, with parallel restoration of cellular immunity indices. Effect sizes are not given in the abstract.
- 18سريري بشري1989· Russian (English abstract)
[Effect of thymalin on immunologic reactivity of patients with non-specific lung diseases].
Dovnar TE, et al. · Ter Arkh · controlled clinical study, n=35 patients with non-specific lung diseases: twenty-one given thymalin in addition to standard treatment and fourteen controls
Thymalin corrected reduced cellular immunity, normalising lymphocyte counts and the OKT-4+/OKT-8+ subset ratio, but had no substantial effect on leukocyte chemotaxis and phagocytosis, immunoglobulins or circulating immune complexes. A clinical benefit was reported in patients with preserved phagocytic function.
- 19سريري بشري1989· Russian (English abstract)
[Thymalin in the combined treatment of patients with chronic lympholeukemia].
Babenko TF, et al. · Vrach Delo · clinical study in patients with stage II B-cell chronic lymphocytic leukaemia given thymalin as part of complex treatment; n and comparison group not stated in the abstract
Including thymalin was reported to improve the functional activity of lymphoid cells and to shorten the time to clinical and haematological remission.
- 20سريري بشري1987· Russian (English abstract)
[Nonspecific and antigen-specific adhesiveness of circulating lymphocytes in dysentery patients undergoing combined therapy using thymalin and indomethacin].
Mats AN, et al. · Zh Mikrobiol Epidemiol Immunobiol · comparative study in patients with dysentery given short courses of thymalin or indomethacin within combined therapy; lymphocyte adhesiveness measured; n not stated in the abstract
Indomethacin, but not thymalin, accelerated normalisation of nonspecific lymphocyte adhesiveness during regression of the disease. Unlike indomethacin, thymalin did not inhibit antigen-specific T-lymphocyte adhesiveness to a Shigella flexneri immunosorbent.
- 21سريري بشري1986· Russian (English abstract)
[Use of thymalin and heparin in acute peritonitis].
Kokotov IuK, et al. · Vestn Khir Im I I Grek · comparative clinical study, n=63 patients with acute peritonitis given thymalin alone or combined with heparin; no untreated control group described in the abstract
Thymalin, alone or with heparin, was reported to bring quicker arrest of the pathological process and of its clinical and laboratory signs, with changes in cellular and humoral immunity and coagulation. The combination was recommended for elderly patients and those at higher risk of thrombosis.
- 22سريري بشري1986· Russian (English abstract)
[Effect of thymalin on the status of immunogenesis and hemostasis in patients with ischemic heart disease].
Kuznik BI, et al. · Ter Arkh · controlled clinical study in patients with ischaemic heart disease and effort and rest angina: thymalin added to multimodal therapy, compared with patients not given the drug; n not stated in the abstract
Thymalin was reported to normalise cellular and humoral immunity, slow blood coagulation, lower fibrinogen and fibrin degradation product levels and enhance fibrinolysis. Angina pain resolved faster than in patients who did not receive the drug.
- 23سريري بشري1986· Russian (English abstract)
[Dynamics of immunological indices in patients with chronic viral hepatitis B and the effect of thymalin therapy].
Gol'zand IV, et al. · Zh Mikrobiol Epidemiol Immunobiol · clinical study, n=102 children with chronic viral hepatitis B treated with thymalin, with T-lymphocyte subsets and antigen sensitisation measured; no control group described in the abstract
Thymalin therapy produced an effect in 71.6% of cases, with clinical and biochemical remission, a rise in T-lymphocytes and normalisation of the suppressor-to-helper ratio. Sensitisation to HBsAg fell from 30.5% to 13.9%, while sensitisation to human liver lipoprotein stayed high after treatment.
- 24سريري بشري1985· Russian (English abstract)
[Use of thymalin in the complex treatment of infantile cerebral palsy].
Mamonova IP · Zh Nevropatol Psikhiatr Im S S Korsakova · clinical study, n=22 children with cerebral palsy (spastic diplegia) and frequent intercurrent infections, thymalin added to rehabilitation therapy; no control group described in the abstract
One month after treatment, improvement in the neurological defect was observed in 54.55% of children with impaired immune function.
- 25سريري بشري1984· Russian (English abstract)
[Use of a thymus polypeptide preparation to diagnose and correct immune deficiency states in multiple sclerosis].
Golovkin VI, et al. · Zh Nevropatol Psikhiatr Im S S Korsakova · clinical study, n=36 patients with multiple sclerosis: T-lymphocyte sensitivity to thymalin, myelin basic protein and prednisolone tested, and thymalin used for treatment
The authors reported positive clinical and immunological results and described this as the first use of thymalin to treat multiple sclerosis. Outcome measures and figures are not given in the abstract.
- 26سريري بشري1984· Russian (English abstract)
[Thymalin as a modulator of immunogenesis and hemostasis].
Kuznik BI, et al. · Farmakol Toksikol · clinical study, n=30 patients with periodontosis treated with thymalin; no control group described in the abstract
Thymalin was reported to improve general health, normalise cellular and to a lesser degree humoral immunity, and normalise blood coagulation and total and Hageman factor-dependent fibrinolysis.
- 27حيواني داخل الجسم الحي2018
Effect of Thymalin on the Tumor and Thymus under Conditions of Activation Therapy In Vivo
Zhukova GV, et al. · Bull Exp Biol Med · outbred male rats with transplanted sarcoma 45, Thymalin given under an "activation therapy" regimen
Thymalin was associated with tumour growth arrest and regression in more than half of the animals and growth suppression of 78% in the rest. Thymus lobules showed increased lymphoproliferative activity and higher tissue basophil and plasma cell content.
- 28حيواني داخل الجسم الحي1989
Effect of low-molecular-weight factors of thymus and pineal gland on life span and spontaneous tumour development in female mice of different age
Anisimov VN, et al. · Mech Ageing Dev · female SHR mice treated from 3.5 or 12 months of age with monthly courses of thymus-derived (TF) or pineal-derived polypeptide factors versus saline
The thymus-derived factor increased life span only in mice treated from a young age, whereas the pineal factor increased life span in both young and middle-aged mice, by 20% and 17%. Both factors given to young mice reduced overall tumour incidence and mammary adenocarcinoma incidence; the thymus factor had no antitumour effect when started in mature mice.
- 29حيواني داخل الجسم الحي1982
Carcinogenesis and aging. IV. Effect of low-molecular-weight factors of thymus, pineal gland and anterior hypothalamus on immunity, tumor incidence and life span of C3H/Sn mice
Anisimov VN, et al. · Mech Ageing Dev · adult CBA mice (skin allograft rejection, antibody response) and female C3H/Sn mice (chronic administration, life span and spontaneous tumours); bovine thymus, pineal and anterior hypothalamus polypeptide factors
The thymus and pineal factors enhanced skin allograft rejection and the antibody response to sheep erythrocytes. Chronic administration of either factor reduced spontaneous tumour development and prolonged life span in female C3H/Sn mice, whereas the hypothalamic factor had no effect.
- 30في المختبر2023
The Influence of KE and EW Dipeptides in the Composition of the Thymalin Drug on Gene Expression and Protein Synthesis Involved in the Pathogenesis of COVID-19
Linkova N, et al. · Int J Mol Sci · molecular modelling and docking of the KE and EW dipeptides with DNA, plus an in vitro inflammation model in human peripheral blood mononuclear cells
Docking predicted interactions of the EW and KE dipeptides, described as active components of Thymalin, with double-stranded DNA and with genes including ACE2, CYSLTR1 and CHUK. In stimulated human mononuclear cells, Thymalin and both dipeptides reduced IL-1beta, IL-6 and TNF-alpha synthesis by 1.4-6.0 times.
- 31في المختبر2022
Peptides Regulating Proliferative Activity and Inflammatory Pathways in the Monocyte/Macrophage THP-1 Cell Line
Avolio F, et al. · Int J Mol Sci · human THP-1 monocyte/macrophage cell line and LPS-activated HUVEC co-culture; Thymalin tested alongside Epitalon, Vilon, Thymogen and Chonluten
All five peptide preparations, including Thymalin, increased tyrosine phosphorylation of mitogen-activated kinases and inhibited LPS-stimulated TNF and IL-6 expression in differentiated THP-1 cells. Peptide-treated cells adhered less to activated endothelial cells.
- 32في المختبر2020
Thymalin: Activation of Differentiation of Human Hematopoietic Stem Cells
Khavinson VK, et al. · Bull Exp Biol Med · human haematopoietic stem cells cultured with Thymalin, markers CD44, CD117 and CD28
Thymalin reduced expression of the stem-cell marker CD44 and the intermediate-differentiation marker CD117 by 2-3 times and increased expression of the mature T-cell marker CD28 by 6.8 times. The authors interpreted this as stimulation of differentiation toward mature T lymphocytes.
- 33مراجعة2021
The Use of Thymalin for Immunocorrection and Molecular Aspects of Biological Activity
Khavinson VK, et al. · Biol Bull Rev · narrative review from the developing group
The review summarised use of Thymalin in immune dysfunction, viral and bacterial infection and suppressed blood-cell formation after chemotherapy and radiotherapy, and attributed its activity to the short peptides EW, KE and EDP, which were reported to regulate gene expression and cytokine and heat-shock protein synthesis. The authors stated that Thymalin and Thymogen have practically no side effects; the abstract cites no systematic safety data.
- 34مراجعة1997
Natural and synthetic thymic peptides as therapeutics for immune dysfunction
Morozov VG, et al. · Int J Immunopharmacol · overview of natural (calf thymus extract, Thymalin) and synthetic (Thymogen, Vilon) thymic peptides from the developing group
Thymalin was described as a calf-thymus extract obtained by mild acid extraction and used in practice as an immunocorrector, and the dipeptide L-Glu-L-Trp (Thymogen) was isolated from it. Natural and synthetic preparations activated T-cell differentiation and altered lymphocyte cyclic nucleotides and IL-2 and interferon release, and natural peptides differed from synthetic ones in antioxidant effects in thymocytes.
ما لا تثبته هذه الأدلة.
There are no independently conducted, randomised, blinded, placebo-controlled trials of Thymalin, and the human longevity and COVID-19 studies come from the developing group, and the other clinical reports are small open-label Soviet-era and Russian studies. The preparation is a mixture of thymus-derived peptides whose composition is not fully characterised in the abstracts reviewed, there is no published human pharmacokinetic work, and no dedicated safety study was found; statements that it has few side effects come from the developers' reviews rather than systematic adverse-event data.
أسئلة شائعة حول البحث.
- What is Thymalin?
Thymalin is a polypeptide complex extracted from calf thymus, developed in the Soviet Union by Morozov and Khavinson and used in Russia as an immunocorrective medicine. It is a mixture rather than a single defined peptide. The dipeptide Thymogen (Glu-Trp) was later isolated from it, and the developing group attributes part of its activity to the short peptides KE and EW.
- What did the human studies of Thymalin report?
A study of 266 older people followed for 6 to 8 years reported a lower incidence of acute respiratory disease and lower mortality in groups given Thymalin, alone or with Epithalamin, than in a control group. During the COVID-19 pandemic the same group reported faster normalisation of inflammatory and coagulation markers in 36 older patients with severe disease when Thymalin was added to standard care, compared with 44 on standard care alone. These studies were small, came from the developing group, and were not described as blinded or placebo-controlled.
- Is Thymalin the same as thymulin or thymosin alpha-1?
No. Thymulin is a single nine-amino-acid peptide and thymosin alpha-1 is a single 28-amino-acid peptide, each with a defined sequence. Thymalin is an extract containing a mixture of thymus-derived peptides whose full composition is not characterised in the published abstracts. Database entries that map the name Thymalin to thymulin are incorrect.
متاح من كتالوجنا
لأغراض البحث فقط. ليس للاستهلاك البشري أو التشخيص أو العلاج أو الوقاية من أي حالة. لا شيء في هذه الصفحة يعتبر نصيحة طبية، ولا ينبغي قراءة أي دراسة ملخصة هنا كتوصية.